-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, by the Chinese Academy of Sciences Lanzhou Chemical Institute and Inner Mongolia Donghui Biotech Co., Ltd. jointly held the "high-value utilization of camel blood resources seminar" held in the chemical institute.
attended the meeting with relevant leaders and experts from Lanzhou Branch of the Chinese Academy of Sciences, Lanzhou University, institute of natural energy of Gansu Academy of Sciences, and Alashan League Science and Technology Bureau of Inner Mongolia.
meeting, the experts discussed the series of key technologies and industrialization for the separation and preparation of camel blood polypeptides.
experts believe that the project gives full play to the advantages of the separation technology of lanzhou chemicals of the Chinese Academy of Sciences, combined with Inner Mongolia's abundant camel resources, the research results in the field of large-scale health industrialization, for the cultivation of regional characteristics of the economy and industry has a positive significance.
it is understood that the albumin in camel blood is not only significantly higher than other animals, but also has abnormally high physiological activity.
, at present, the research and development of camel blood at home and abroad is still in a blank stage, the domestic camel blood has not been industrialization development.
researchers developed an integrated technology with independent intellectual property rights, integrating enzyme solution, separation, decolorization, de-fishing, refining, drying and other technologies in one, and with Inner Mongolia Donghui Biotech Co., Ltd. for production, research and development, to achieve the industrialization of camel blood polypeptide production technology.
.